Released By Bachem News Releases Interview with Phillip Karbach, COOO/CFO of AMW We sat down with Philipp Karbach, COO and CFO of AMW, to ask about his experience collaborating with Bachem
Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes
When using semaglutide, a medication often prescribed to manage type 2 diabetes or obesity, specific lifestyle changes can significantly enhance its effectiveness and contribute to improved overall health
Exercise may deplete the corresponding metabolites of intestinal microorganisms
To understand why, imagine your stomach as a container with an entrance at the top and an exit at the bottom
The four largest hyperscalers committed roughly $725 billion in 2026 capex, nearly double 2025 levels